Modeling Pharmacodynamic Biomarkers related to CDK4/6 Inhibition and Cell Cycle Modulation in Patients with Advanced Breast Cancer

被引：0
|
作者：
Sun, Wan [1 ]
Liu, Yuan [1 ]
Wang, Diane [1 ]
机构：
[1] Pfizer, Clin Pharmacol, San Diego, CA USA
来源：
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS | 2018年 / 45卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
M-042
引用
收藏
页码：S22 / S23
页数：2
相关论文
共 50 条
  • [41] Circulating tumor DNA dynamics in advanced breast cancer treated with CDK4/6 inhibition and endocrine therapy
    Martinez-Saez, Olga
    Pascual, Tomas
    Braso-Maristany, Fara
    Chic, Nuria
    Gonzalez-Farre, Blanca
    Sanfeliu, Esther
    Rodriguez, Adela
    Martinez, Debora
    Galvan, Patricia
    Rodriguez, Anna Belen
    Schettini, Francesco
    Conte, Benedetta
    Vidal, Maria
    Adamo, Barbara
    Martinez, Antoni
    Munoz, Montserrat
    Moreno, Reinaldo
    Villagrasa, Patricia
    Salvador, Fernando
    Ciruelos, Eva M.
    Faull, Iris
    Odegaard, Justin I.
    Prat, Aleix
    NPJ BREAST CANCER, 2021, 7 (01)
  • [42] Circulating tumor DNA dynamics in advanced breast cancer treated with CDK4/6 inhibition and endocrine therapy
    Olga Martínez-Sáez
    Tomás Pascual
    Fara Brasó-Maristany
    Nuria Chic
    Blanca González-Farré
    Esther Sanfeliu
    Adela Rodríguez
    Débora Martínez
    Patricia Galván
    Anna Belén Rodríguez
    Francesco Schettini
    Benedetta Conte
    Maria Vidal
    Barbara Adamo
    Antoni Martínez
    Montserrat Muñoz
    Reinaldo Moreno
    Patricia Villagrasa
    Fernando Salvador
    Eva M. Ciruelos
    Iris Faull
    Justin I. Odegaard
    Aleix Prat
    npj Breast Cancer, 7
  • [43] CDK4/6 inhibitors: mechanisms of resistance and potential biomarkers of responsiveness in breast cancer
    Cetin, Bulent
    Wabl, Chiara A.
    Gumusay, Ozge
    FUTURE ONCOLOGY, 2022, 18 (09) : 1143 - 1157
  • [44] Mechanisms of Resistance to CDK4/6 Inhibitors in Breast Cancer and Potential Biomarkers of Response
    Guarducci, Cristina
    Bonechi, Martina
    Boccalini, Giulia
    Benelli, Matteo
    Risi, Emanuela
    Di Leo, Angelo
    Malorni, Luca
    Migliaccio, Ilenia
    BREAST CARE, 2017, 12 (05) : 304 - 308
  • [45] Update on CDK4/6 Inhibitors in Breast Cancer
    Tolaney, Sara M.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2024, 22 (06) : 298 - 300
  • [46] The Role of CDK4/6 Inhibitors in Breast Cancer
    Murphy, Conleth G.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2019, 20 (06)
  • [47] The Role of CDK4/6 Inhibitors in Breast Cancer
    Conleth G. Murphy
    Current Treatment Options in Oncology, 2019, 20
  • [48] CDK4/6 inhibitors in luminal breast cancer
    Gnant, Michael
    Steger, Guenther G.
    Bartsch, Rupert
    LANCET ONCOLOGY, 2015, 16 (01): : 2 - 3
  • [49] MCL PATIENTS RESPOND TO CDK4/6 INHIBITION
    不详
    CANCER DISCOVERY, 2012, 2 (04) : 300 - 300
  • [50] Targeting CDK4/6 in patients with cancer
    Hamilton, Erika
    Infante, Jeffrey R.
    CANCER TREATMENT REVIEWS, 2016, 45 : 129 - 138
12345